Risk factors of pulmonary arterial hypertension in patients with systemic lupus erythematosus: A meta-analysis
- 12 September 2023
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 32 (11) , 1310-1319
Abstract
Objective: To determine the risk factors of pulmonary arterial hypertension (PAH) related to systemic lupus erythematosus (SLE) through systematic reviews and meta-analyses. Methods: We undertook electronic search strategies using Medline via PubMed, Embase, Web of Science, and Cochrane Library up to April 11, 2023. Study selection and data extraction were performed by 2 authors independently. We made risk of bias judgments based on the Newcastle-Ottawa Scale (NOS). Pooled risk ratios (RRs) and 95% confidence intervals (CIs) were calculated to estimate the overall effect sizes of potential risk factors for PAH in SLE patients. Univariate and multivariate meta-regression models were used to assess the independent effects of each risk factor on PAH. Sensitivity analyses were also conducted to explore potential sources of heterogeneity. Results: A total of 19 articles were included in this meta-analysis, and the results showed that gender (female) [RR = 1.04, 95% CI (1.02, 1.06), p = .0001], interstitial lung disease [RR = 4.36, 95% CI (2.42, 7.85), p = .0001], alopecia [RR = 1.39, 95% CI (1.06, 1.83), p = .017], Raynaud’s phenomenon [RR = 1.83, 95% CI (1.41, 2.37), p = .0001], systemic hypertension [RR = 1.30, 95% CI (1.07, 1.58), p = .007], serositis [RR = 2.29, 95% CI (1.89, 2.77), p = .0001], pericardial effusion [RR = 3.33, 95% CI (2.20, 5.05), p = .0001], anti-RNP [RR = 1.86, 95% CI (1.19, 2.91), p = .006], anti-SSA [RR = 1.28, 95% CI (1.01, 1.62), p = .041], anti-SSB [RR = 1.38, 95% CI (1.19, 1.60), p = .0001], anti-U1RNP [RR = 1.58, 95% CI (1.07, 2.34), p = .023], thrombocytopenia [RR = 1.38, 95% CI (1.14, 1.68), p = .001], and current smokers [RR = 2.20, 95% CI (1.19, 4.06), p = .012] were all risk factors for PAH related to SLE. Conclusion: PAH is a serious complication of SLE. Since prognosis of SLE patients after the occurrence of PAH is poor, routine examination should be conducted for SLE patients with PAH risk factors.Keywords
This publication has 33 references indexed in Scilit:
- Systemic Lupus ErythematosusNew England Journal of Medicine, 2011
- Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosusEuropean Respiratory Review, 2011
- Clinical features and independent predictors of pulmonary arterial hypertension in systemic lupus erythematosusRheumatology International, 2011
- Predicting Survival in Pulmonary Arterial HypertensionCirculation, 2010
- Guidelines for the diagnosis and treatment of pulmonary hypertensionEuropean Respiratory Journal, 2009
- Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease and Interstitial Lung DiseasesSeminars in Respiratory and Critical Care Medicine, 2009
- Raynaud's phenomenon is correlated with elevated systolic pulmonary arterial pressure in patients with systemic lupus erythematosusLupus, 2007
- Primary pulmonary hypertension. Its association with microangiopathic hemolytic anemia and thrombocytopeniaArchives of internal medicine (1960), 1991
- Pulmonary vascular structure and function in chronic obstructive pulmonary disease.Thorax, 1988
- Pulmonary Hypertension in PolymyositisChest, 1981